Skip to content

The identification of phenotypes in patients with severe Chronic Obstructive Pulmonary Disease

The identification of phenotypes in patients with severe Chronic Obstructive Pulmonary Disease - Phenotyping in COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40211
Enrollment
1000
Registered
2014-05-19
Start date
2014-08-14
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD) emphysema

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Referral to the LVR intervention team or LTx team of the UMCG. • Chronic Obstructive Pulmonary Disease (COPD) according the Global initiative for Chronic Obstructive Lung Disease (GOLD) criteria (post bronchodilator FEV1/FVC

Exclusion criteria

Exclusion criteria: There are no exclusion criteria for this study.

Design outcomes

Primary

MeasureTime frame
The main study parameter is the identification of new clinical phenotypes. The collected data will allow us to identify new phenotypes, clusters of patients with similar characteristics. These phenotypes are potentially based on a combination of lung function parameters, clinical parameters, radiologic parameters, and systemic parameters and genotypes and endotypes, in patients with severe COPD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)